Here, we extend those findings with the measurements of proliferation (Ki67) and apoptosis (caspase 3 activation) showing that apoptosis may well contribute to the ability of the compound to slow the growth of the resistant melanoma in vivo. The gene discussed is CASP3; the disease is melanoma.